About
AIQ Solutions develops FDA-cleared AI-powered software that analyzes PET/CT scans to quantify treatment response and lesion heterogeneity in metastatic cancer, enabling oncologists to tailor therapies and improve patient outcomes.
Explore AIQ Solutions's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.